longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Stocks to watch: CSE Global, Marco Polo Marine, iX Biopharma

Businesstimes News
Sep 7, 2026 at 12:36 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

CSE Global received a preliminary strategic review report from adviser Jefferies, with no assurance of a transaction. Marco Polo Marine entered a conditional agreement for a reverse takeover valued up to S$139 million.

[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Monday (Sep 7):

CSE Global : The company on Friday said its appointed financial adviser – Jefferies Singapore – in connection with the strategic review, has submitted a preliminary report which the board of CSE Global is currently reviewing. It added that there is “no certainty or assurance” any definitive agreement will be entered into, or any transaction will materialise from the strategic review. Shares of CSE Global ended 1.7 per cent or S$0.02 higher at S$1.18 prior to the news.

Marco Polo Marine : On Monday, it entered a conditional sale and purchase agreement with Fuji Offset Plates Manufacturing, in relation to a proposed reverse takeover transaction announced on May 15. The consideration of the proposed takeover is up to S$139 million, and comprises a base consideration of S$120 million and a deferred consideration of up to S$19 million. Shares of Marco Polo Marine ended 0.8 per cent or S$0.001 higher at S$0.129 before the news.

Login to unlock554characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

CSE Global

CSE Global

SG544

-4.00%

MarcoPolo Marine

MarcoPolo Marine

SG5LY

-2.16%

IX Biopharma

IX Biopharma

SG42C

LongbridgeAI